Clinical Trial Update: German Preoperative Adriamycin Docetaxel Study [Phase 2]

View source ↗

Summary

Phase 2 preoperative study of Adriamycin (doxorubicin) and docetaxel in breast cancer has completed in Germany.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED